Full-Text Search:
Home|About CNKI|User Service|中文
Add to Favorite Get Latest Update

Clinical Trial on the Treatment of Non-Small Cell Lung Cancer with Taxol Plus DDP

WT5,5”BZ]ZHANG Li,ZHOU Zhong mei,MA Guo sheng (Sun Yat Sen University of Medical Science,Tumor Hospital,Guangzhou 510060,China)  
urpose〕To observe the efficacy and the toxicity of non small cell lung cancer patients treated with taxol plus DDP regimen.〔Methods〕Thirty three initial treated patients with non small cell lung cancer were treated with Taxol plus DDP regimen. All patients received two cycles chemotherapy.〔Results〕The overall response rate was 44.12%,including 15 PR,13 NC,6 PD.The side effects were bone marrow suppression,nausea and vomiting,myalgia and arthritis,alopecia.No life threatening severe side effect and allergic reaction occurred in this clinical trial.〔Conclusion〕Taxol plus DDP is an effective regimen for non small cell lung cancer.It shows this regimen was safe and well tolerated.
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©CNKI All Rights Reserved